Pharmacological inhibition on the ataxia telangiectasia and Rad3-linked protein serine/threonine kinase (ATR; often called FRAP-relevant protein (FRP1)) has emerged as a promising technique for most cancers therapy that exploits artificial lethal interactions with proteins involved in DNA destruction repair service, overcomes resistance to other th